Eiger BioPharmaceuticals, Inc.
EIGRDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001305253
Eiger BioPharmaceuticals, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 43 institutions reported holding it in 13F filings for Q4 2023, worth $4.16M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Eiger BioPharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 86
- −4 vs. Q3 2021
- Shares held
- 23.9M
- +1.64M (+7.4%) vs. Q3 2021
- Total value
- $124.1M
- −$24.8M (−16.6%) vs. Q3 2021
- New holders
- 16
- 31 more added
- Sold out
- 20
- 19 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EIGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $423.0K |
| Q1 2025 | 1 | $423.0K |
| Q4 2024 | 1 | $765.0K |
| Q3 2024 | 1 | $1.24M |
| Q2 2024 | 2 | $1.85M |
| Q1 2024 | 24 | $3.19M |
| Q4 2023 | 43 | $4.16M |
| Q3 2023 | 51 | $6.08M |
| Q2 2023 | 67 | $14.6M |
| Q1 2023 | 71 | $22.2M |
| Q4 2022 | 81 | $29.6M |
| Q3 2022 | 92 | $225.3M |
| Q2 2022 | 91 | $187.8M |
| Q1 2022 | 95 | $252.0M |
| Q4 2021 | 86 | $124.1M |
| Q3 2021 | 92 | $151.0M |
| Q2 2021 | 90 | $196.3M |
| Q1 2021 | 94 | $207.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Eiger BioPharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invesco Ltd. | 0 | $0 | 0.00% | −11,461−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,253−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −6,450−100.0% | Sold out |
| Pflug Koory, LLC | 0 | $0 | 0.00% | −1,010−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −775−100.0% | Sold out |
| Knott David M | – | – | – | – | Not filed |
| Sonora Investment Management, LLC | – | – | – | – | Not filed |